Form 4: IBM CFO Kavanaugh Receives Significant Equity Grants

IBM's Senior VP and CFO, James J. Kavanaugh, reported the acquisition of 10,364 Restricted Stock Units and 41,455 Employee Stock Options.

Summary

• James J. Kavanaugh, IBM's Senior VP and CFO, acquired 10,364 Restricted Stock Units (RSUs) and 41,455 Employee Stock Options (ESOs) on February 26, 2026.
• The RSUs have a price of $0.00 and will vest in four equal annual installments of 2,591 units each, starting on February 26, 2027, and continuing through February 26, 2030.
• These RSUs are payable in cash or IBM common stock upon the lapse of restrictions.
• The ESOs have an exercise price of $243.22 and will vest in four equal annual installments, with the first vesting on February 26, 2027.
• All ESOs will expire on February 25, 2036.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, primarily for the executive, as it represents routine compensation and aligns management's interests with shareholders. It is neutral for the company's immediate operational or financial outlook.

Positives

• The equity grants align the interests of a key executive, James J. Kavanaugh, with those of shareholders, incentivizing long-term performance.
• The grants represent a significant component of executive compensation, reflecting continued commitment to the company's leadership.

Industry Context

StockSavvy.ai notes that equity compensation, including Restricted Stock Units and Employee Stock Options, is a standard practice for executive retention and performance alignment across the technology and broader corporate sectors. These grants are typical for a senior executive at a large, publicly traded company.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure and size of these equity grants are consistent with compensation packages for CFOs at comparable large-cap technology companies such as Microsoft, Oracle, or Cisco, where long-term incentives form a significant portion of total compensation.
• The vesting schedules, typically over several years, are standard for promoting executive retention and linking compensation to sustained company performance.

Stakeholder Impact

• Shareholders: The grants represent potential future dilution as shares are issued upon vesting, but also serve to align executive incentives with long-term shareholder value creation.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of Restricted Stock Units will occur annually on February 26, from 2027 to 2030.
• Employee Stock Options will vest in four equal annual installments, with the first vesting on February 26, 2027.

Key Dates

Recommendation

This Form 4 reports routine equity compensation grants to a senior executive, which is a standard practice for executive retention and performance alignment. It does not provide new information that would alter the fundamental investment thesis for IBM, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

IBM, Insider Transaction, Equity Compensation, Restricted Stock Units, Stock Options, Executive Compensation, Form 4, James J. Kavanaugh